Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery.

Leong SP, Wu M, Lu Y, Torre DM, von Bakonyi A, Ospina AM, Newsom JD, Luckett WS, Soon CW, Kim KB, Kashani-Sabet M.

Ann Surg Oncol. 2018 Oct;25(11):3326-3333. doi: 10.1245/s10434-018-6685-1. Epub 2018 Aug 13.

PMID:
30105436
2.

PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.

de Semir D, Bezrookove V, Nosrati M, Dar AA, Wu C, Shen J, Rieken C, Venkatasubramanian M, Miller JR 3rd, Desprez PY, McAllister S, Soroceanu L, Debs RJ, Salomonis N, Schadendorf D, Cleaver JE, Kashani-Sabet M.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5766-E5775. doi: 10.1073/pnas.1804779115. Epub 2018 Jun 4.

PMID:
29866840
3.

Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.

Bezrookove V, Nosrati M, Miller JR 3rd, De Semir D, Dar AA, Vosoughi E, Vaquero E, Sucker A, Lazar AJ, Gershenwald JE, Davies MA, Schadendorf D, Kashani-Sabet M.

Clin Cancer Res. 2018 Sep 1;24(17):4119-4125. doi: 10.1158/1078-0432.CCR-18-0791. Epub 2018 May 18.

PMID:
29776954
4.

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies.

Vosoughi E, Lee JM, Miller JR, Nosrati M, Minor DR, Abendroth R, Lee JW, Andrews BT, Leng LZ, Wu M, Leong SP, Kashani-Sabet M, Kim KB.

BMC Cancer. 2018 Apr 27;18(1):490. doi: 10.1186/s12885-018-4374-x.

5.

Stratifying SLN incidence in intermediate thickness melanoma patients.

Chang JM, Kosiorek HE, Dueck AC, Leong SPL, Vetto JT, White RL, Avisar E, Sondak VK, Messina JL, Zager JS, Garberoglio C, Kashani-Sabet M, Pockaj BA.

Am J Surg. 2018 Apr;215(4):699-706. doi: 10.1016/j.amjsurg.2017.12.009. Epub 2017 Dec 14.

6.

Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapy.

Jiang B, Patino MM, Gross AJ, Leong SPL, Moretto JC, Kashani-Sabet M, Kim KB.

JAAD Case Rep. 2017 Dec 18;4(1):13-16. doi: 10.1016/j.jdcr.2017.06.014. eCollection 2018 Jan. No abstract available.

7.

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.

Faries MB, Mozzillo N, Kashani-Sabet M, Thompson JF, Kelley MC, DeConti RC, Lee JE, Huth JF, Wagner J, Dalgleish A, Pertschuk D, Nardo C, Stern S, Elashoff R, Gammon G, Morton DL; MMAIT-IV Clinical Trial Group.

Ann Surg Oncol. 2017 Dec;24(13):3991-4000. doi: 10.1245/s10434-017-6072-3. Epub 2017 Oct 10.

PMID:
29019177
8.

Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690.

Kashani-Sabet M, Nosrati M, Miller JR 3rd, Sagebiel RW, Leong SPL, Lesniak A, Tong S, Lee SJ, Kirkwood JM.

Clin Cancer Res. 2017 Nov 15;23(22):6888-6892. doi: 10.1158/1078-0432.CCR-17-1317. Epub 2017 Aug 8.

PMID:
28790109
9.

Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?

Rios-Cantu A, Lu Y, Melendez-Elizondo V, Chen M, Gutierrez-Range A, Fadaki N, Thummala S, West-Coffee C, Cleaver J, Kashani-Sabet M, Leong SPL.

Clin Exp Metastasis. 2017 Jun;34(5):345-350. doi: 10.1007/s10585-017-9854-x. Epub 2017 Jul 11.

10.

Is pelvic sentinel node biopsy necessary for lower extremity and trunk melanomas?

Schuitevoerder D, Leong SPL, Zager JS, White RL, Avisar E, Kosiorek H, Dueck A, Fortino J, Kashani-Sabet M, Hart K, Vetto JT.

Am J Surg. 2017 May;213(5):921-925. doi: 10.1016/j.amjsurg.2017.03.028. Epub 2017 Mar 27.

PMID:
28411863
11.

The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.

Jones MS, Jones PC, Stern SL, Elashoff D, Hoon DSB, Thompson J, Mozzillo N, Nieweg OE, Noyes D, Hoekstra HJ, Zager JS, Roses DF, Testori A, Coventry BJ, Smithers MB, Andtbacka R, Agnese D, Schultz E, Hsueh EC, Kelley M, Schneebaum S, Jacobs L, Bowles T, Kashani-Sabet M, Johnson D, Faries MB.

Ann Surg Oncol. 2017 Aug;24(8):2089-2094. doi: 10.1245/s10434-017-5775-9. Epub 2017 Feb 21.

12.

Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma.

Danielsen M, Kjaer A, Wu M, Martineau L, Nosrati M, Leong SP, Sagebiel RW, Miller JR III, Kashani-Sabet M.

Am J Nucl Med Mol Imaging. 2016 Sep 22;6(5):277-285. eCollection 2016.

13.

BPTF transduces MITF-driven prosurvival signals in melanoma cells.

Dar AA, Majid S, Bezrookove V, Phan B, Ursu S, Nosrati M, De Semir D, Sagebiel RW, Miller JR 3rd, Debs R, Cleaver JE, Kashani-Sabet M.

Proc Natl Acad Sci U S A. 2016 May 31;113(22):6254-8. doi: 10.1073/pnas.1606027113. Epub 2016 May 16.

14.

Selective Sentinel Lymph Node Dissection in Lower Extremity Melanoma.

Miranda SG, Parrett BM, Li RR, Lee G, Chang T, Fadaki N, Cardona-Huerta S, Cleaver JE, Kashani-Sabet M, Leong SP.

Plast Reconstr Surg. 2016 Mar;137(3):1031-8. doi: 10.1097/01.prs.0000479990.65243.eb. Erratum in: Plast Reconstr Surg. 2016 Apr;137(4):1357.

PMID:
26809037
15.

Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.

Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M, Dar AA.

Oncotarget. 2016 Apr 12;7(15):19519-30. doi: 10.18632/oncotarget.6961.

16.

The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.

Dar AA, Nosrati M, Bezrookove V, de Semir D, Majid S, Thummala S, Sun V, Tong S, Leong SP, Minor D, Billings PR, Soroceanu L, Debs R, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M.

J Natl Cancer Inst. 2015 Feb 23;107(5). pii: djv034. doi: 10.1093/jnci/djv034.

17.

Antitumor activity of miR-1280 in melanoma by regulation of Src.

Sun V, Zhou WB, Nosrati M, Majid S, Thummala S, de Semir D, Bezrookove V, de Feraudy S, Chun L, Schadendorf D, Debs R, Kashani-Sabet M, Dar AA.

Mol Ther. 2015 Jan;23(1):71-8. doi: 10.1038/mt.2014.176. Epub 2014 Sep 8.

18.

The safety of and indications for immediate reconstruction of head and neck melanoma defects: our early experience.

Parrett BM, Kashani-Sabet M, Leong SP, Buncke N, Singer MI.

Ann Plast Surg. 2014 May;72 Suppl 1:S35-7. doi: 10.1097/SAP.0000000000000166.

PMID:
24691340
19.

MicroRNA-mediated regulation of melanoma.

Sun V, Zhou WB, Majid S, Kashani-Sabet M, Dar AA.

Br J Dermatol. 2014 Aug;171(2):234-41. doi: 10.1111/bjd.12989. Epub 2014 Jul 26. Review.

PMID:
24665835
20.

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB; MSLT Group.

N Engl J Med. 2014 Feb 13;370(7):599-609. doi: 10.1056/NEJMoa1310460.

21.

Immunohistochemical diagnostic and prognostic markers for melanoma.

Nosrati M, Kashani-Sabet M.

Methods Mol Biol. 2014;1102:259-73. doi: 10.1007/978-1-62703-727-3_14.

PMID:
24258983
22.

Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.

Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, Djulbegovic M, Weber JL, Marzban SS, Sondak VK, Messina JL, Vetto JT, White RL, Pockaj B, Mozzillo N, Charney KJ, Avisar E, Krouse R, Kashani-Sabet M, Leong SP.

J Clin Oncol. 2013 Dec 10;31(35):4387-93. doi: 10.1200/JCO.2013.50.1114. Epub 2013 Nov 4.

PMID:
24190111
23.

Prognostic impact of PHIP copy number in melanoma: linkage to ulceration.

Bezrookove V, De Semir D, Nosrati M, Tong S, Wu C, Thummala S, Dar AA, Leong SPL, Cleaver JE, Sagebiel RW, Miller JR 3rd, Kashani-Sabet M.

J Invest Dermatol. 2014 Mar;134(3):783-790. doi: 10.1038/jid.2013.369. Epub 2013 Sep 4.

24.

Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases.

Ruschulte H, Shi S, Tseng WW, Kolodzie K, Crawford PC, Schneider DB, Kashani-Sabet M, Minor D, Apfel C, Leong SP.

BMC Anesthesiol. 2013 Jul 17;13(1):15. doi: 10.1186/1471-2253-13-15.

25.

Molecular markers in melanoma.

Kashani-Sabet M.

Br J Dermatol. 2014 Jan;170(1):31-5. doi: 10.1111/bjd.12493. Review.

PMID:
23815339
26.

Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".

Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabr├▓ L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M, Ferrone S, Fox BA, Gajewski TF, Galon J, Gnjatic S, Gogas H, Kashani-Sabet M, Kaufman HL, Larkin J, Lo RS, Mantovani A, Margolin K, Melief C, McArthur G, Palmieri G, Puzanov I, Ribas A, Seliger B, Sosman J, Suenaert P, Tarhini AA, Trinchieri G, Vidal-Vanaclocha F, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2013 Jun 3;11:137. doi: 10.1186/1479-5876-11-137.

27.

Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?

Fadaki N, Li R, Parrett B, Sanders G, Thummala S, Martineau L, Cardona-Huerta S, Miranda S, Cheng ST, Miller JR 3rd, Singer M, Cleaver JE, Kashani-Sabet M, Leong SP.

Ann Surg Oncol. 2013 Sep;20(9):3089-97. doi: 10.1245/s10434-013-2977-7. Epub 2013 May 7.

PMID:
23649930
28.

A patient-centered methodology that improves the accuracy of prognostic predictions in cancer.

Kashani-Sabet M, Sagebiel RW, Joensuu H, Miller JR 3rd.

PLoS One. 2013;8(2):e56435. doi: 10.1371/journal.pone.0056435. Epub 2013 Feb 27. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/2db613f0-06cc-47e7-bde2-7c61bc792bb9.

29.

Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children.

Cordoro KM, Gupta D, Frieden IJ, McCalmont T, Kashani-Sabet M.

J Am Acad Dermatol. 2013 Jun;68(6):913-25. doi: 10.1016/j.jaad.2012.12.953. Epub 2013 Feb 8.

PMID:
23395590
30.

The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.

Dar AA, Majid S, Rittsteuer C, de Semir D, Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR 3rd, Kashani-Sabet M.

J Natl Cancer Inst. 2013 Mar 20;105(6):433-42. doi: 10.1093/jnci/djt003. Epub 2013 Jan 30.

31.

Analysis of sentinel lymph node positivity in patients with thin primary melanoma.

Venna SS, Thummala S, Nosrati M, Leong SP, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M.

J Am Acad Dermatol. 2013 Apr;68(4):560-567. doi: 10.1016/j.jaad.2012.08.045. Epub 2012 Nov 19.

PMID:
23182069
32.

Inoperable bulky melanoma responds to neoadjuvant therapy with vemurafenib.

Fadaki N, Cardona-Huerta S, Martineau L, Thummala S, Cheng ST, Bunker SR, Garcia-Kennedy R, Wang W, Minor D, Kashani-Sabet M, Leong SP.

BMJ Case Rep. 2012 Oct 22;2012. pii: bcr2012007034. doi: 10.1136/bcr-2012-007034.

33.

The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival.

Parrett BM, Accortt NA, Li R, Dosanjh AS, Thummala S, Kullar R, Cleaver JE, Kashani-Sabet M, Leong SP.

Melanoma Res. 2012 Oct;22(5):386-91. doi: 10.1097/CMR.0b013e32835861f6.

PMID:
22955010
34.

Progression of cutaneous melanoma: implications for treatment.

Leong SP, Mihm MC Jr, Murphy GF, Hoon DS, Kashani-Sabet M, Agarwala SS, Zager JS, Hauschild A, Sondak VK, Guild V, Kirkwood JM.

Clin Exp Metastasis. 2012 Oct;29(7):775-96. doi: 10.1007/s10585-012-9521-1. Epub 2012 Aug 15. Review. Erratum in: Clin Exp Metastasis. 2012 Oct;29(7):797-9.

35.

Comparing Melanoma Invasiveness in Dermatologist- versus Patient-Detected Lesions: A Retrospective Chart Review.

Lamerson CL, Eaton K, Sax JL, Kashani-Sabet M.

J Skin Cancer. 2012;2012:187963. doi: 10.1155/2012/187963. Epub 2012 Jul 16.

36.

Successful desensitization in a case of Stevens-Johnson syndrome due to vemurafenib.

Minor DR, Rodvien R, Kashani-Sabet M.

Melanoma Res. 2012 Oct;22(5):410-1. doi: 10.1097/CMR.0b013e3283573437.

PMID:
22828249
37.

Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).

Howard JH, Thompson JF, Mozzillo N, Nieweg OE, Hoekstra HJ, Roses DF, Sondak VK, Reintgen DS, Kashani-Sabet M, Karakousis CP, Coventry BJ, Kraybill WG, Smithers BM, Elashoff R, Stern SL, Cochran AJ, Faries MB, Morton DL.

Ann Surg Oncol. 2012 Aug;19(8):2547-55. doi: 10.1245/s10434-012-2398-z. Epub 2012 May 31.

38.

Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition.

Zimmer L, Hillen U, Livingstone E, Lacouture ME, Busam K, Carvajal RD, Egberts F, Hauschild A, Kashani-Sabet M, Goldinger SM, Dummer R, Long GV, McArthur G, Scherag A, Sucker A, Schadendorf D.

J Clin Oncol. 2012 Jul 1;30(19):2375-83. doi: 10.1200/JCO.2011.41.1660. Epub 2012 May 21.

39.

Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma.

Parrett BM, Kashani-Sabet M, Singer MI, Li R, Thummala S, Fadaki N, Leong SP.

Otolaryngol Head Neck Surg. 2012 Oct;147(4):699-706. Epub 2012 Apr 24.

PMID:
22535913
40.

Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis.

De Semir D, Nosrati M, Bezrookove V, Dar AA, Federman S, Bienvenu G, Venna S, Rangel J, Climent J, Meyer Tamg├╝ney TM, Thummala S, Tong S, Leong SP, Haqq C, Billings P, Miller JR 3rd, Sagebiel RW, Debs R, Kashani-Sabet M.

Proc Natl Acad Sci U S A. 2012 May 1;109(18):7067-72. doi: 10.1073/pnas.1119949109. Epub 2012 Apr 17.

41.

Sunitinib therapy for melanoma patients with KIT mutations.

Minor DR, Kashani-Sabet M, Garrido M, O'Day SJ, Hamid O, Bastian BC.

Clin Cancer Res. 2012 Mar 1;18(5):1457-63. doi: 10.1158/1078-0432.CCR-11-1987. Epub 2012 Jan 18.

42.

In-transit intramammary sentinel lymph nodes from malignant melanoma of the trunk.

Lyo V, Jaigirdar AA, Thummala S, Morita ET, Treseler PA, Kashani-Sabet M, Leong SP.

Ann Surg. 2012 Jan;255(1):122-7. doi: 10.1097/SLA.0b013e31823c0890.

PMID:
22143205
43.

Erratum: Cutaneous Spitzoid melanoma in a very young girl of Asian descent.

Miranda SG, Kashani-Sabet M, Zedek D, McCalmont TH, Leong SP.

BMJ Case Rep. 2011;2011:bcr0920103343corr1. doi: 10.1136/bcr.09.2010.3343.corr1. Epub 2011 Jun 30.

44.

The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival.

Baehner FL, Li R, Jenkins T, Hwang J, Kashani-Sabet M, Allen RE, Leong SP.

Ann Surg Oncol. 2012 Mar;19(3):1034-42. doi: 10.1245/s10434-011-2095-3. Epub 2011 Oct 12.

PMID:
21989664
45.

Patellar metastatic melanoma in a 13-year-old boy.

Burk TF, Horvai AE, Gottschalk AR, Leong SP, Kashani-Sabet M, Goldsby RE, Law J, O'Donnell RJ.

Am J Orthop (Belle Mead NJ). 2010 Dec;39(12):582-6. Review.

PMID:
21720575
46.

Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.

White RL Jr, Ayers GD, Stell VH, Ding S, Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ, Avisar E, Hauschild A, Egberts F, Averbook BJ, Garberoglio CA, Vetto JT, Ross MI, Chu D, Trisal V, Hoekstra H, Whitman E, Wanebo HJ, Debonis D, Vezeridis M, Chevinsky A, Kashani-Sabet M, Shyr Y, Berry L, Zhao Z, Soong SJ, Leong SP; Sentinel Lymph Node Working Group.

Ann Surg Oncol. 2011 Dec;18(13):3593-600. doi: 10.1245/s10434-011-1826-9. Epub 2011 Jun 7.

47.

Cutaneous melanoma: a model to study cancer metastasis.

Leong SP, Gershenwald JE, Soong SJ, Schadendorf D, Tarhini AA, Agarwala S, Hauschild A, Soon CW, Daud A, Kashani-Sabet M.

J Surg Oncol. 2011 May 1;103(6):538-49. doi: 10.1002/jso.21816. Review.

PMID:
21480247
48.

Selective sentinel lymph node dissection for melanoma: importance of harvesting nodes with lower radioactive counts without the need for blue dye.

Liu LC, Parrett BM, Jenkins T, Lee W, Morita E, Treseler P, Huang L, Thummala S, Allen RE, Kashani-Sabet M, Leong SP.

Ann Surg Oncol. 2011 Oct;18(10):2919-24. doi: 10.1245/s10434-011-1689-0. Epub 2011 Apr 6.

PMID:
21468784
49.

miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.

Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M.

J Biol Chem. 2011 May 13;286(19):16606-14. doi: 10.1074/jbc.M111.227611. Epub 2011 Mar 24.

50.

Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010".

Ascierto PA, De Maio E, Bertuzzi S, Palmieri G, Halaban R, Hendrix M, Kashani-sabet M, Ferrone S, Wang E, Cochran A, Rivoltini L, Lee PP, Fox BA, Kirkwood JM, Ullmann CD, Lehmann FF, Sznol M, Schwartzentruber DJ, Maio M, Flaherty K, Galon J, Ribas A, Yang J, Stroncek DF, Mozzillo N, Marincola FM.

J Transl Med. 2011 Mar 26;9:32. doi: 10.1186/1479-5876-9-32.

Supplemental Content

Loading ...
Support Center